Halozyme Therapeutics Expands Licensing Agreement With Argenx
Halozyme Therapeutics is expanding its partnership with Argenx, granting the immunology company access to its Enhanze drug delivery technology with two additional exclusive targets.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Halozyme Therapeutics Expands Licensing Agreement With Argenx
By Elias Schisgall Halozyme Therapeutics is expanding its partnership with Argenx, allowing the immunology company access to its Enhanze drug delivery technology with two additional exclusive targets. Halozyme said Tuesday that its global collaboration and licensing agreement with Argenx now covers the use of Enhanze f